Key facts
- This page summarizes Bruce L. Claflin's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 May 2024, 17:00.
Bruce L. Claflin - 17 May 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- Director
- Issuer ticker
- IDXX
- Reported as of
- 17 May 2024
- Net transaction value
- -$108,160
- SEC form
- 4
- Accepted by SEC
- 20 May 2024, 17:00:34 UTC
- Prior SEC filing
- 08 May 2024
- Next SEC filing
- 08 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Bruce L. Claflin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Bruce L. Claflin filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 20 May 2024.
Change
- Previous filing in this sequence was filed on 08 May 2024.
- Current net transaction value: -$108,160.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Sale
- Transaction value
- $108,160
- Shares
- -200
- Change %
- -55%
- Price
- $540.80
- Shares after
- 161
- Date
- 17 May 2024
- Ownership
- Direct
IDXX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,560
- Date
- 17 May 2024
- Ownership
- by Claflin Family Trust
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares of Issuer common stock held by the Claflin Family Trust ('Trust') of which the reporting person's spouse is the trustee for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of the shares held in the Trust and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.